A comparison of the efficacy of azelaic acid 20% cream versus clindamycin 1% gel in treatment of acne

Message:
Abstract:
Background and Objectives
Resistance Strains of propionibacterium acnes is one of the most growing problems in acne treatment. Azelaic acid, due to the lack of bacterial resistance, could be a useful alternative in topical treatment of acne. The purpose of this study was to investigate the therapeutic effects and side effects of azelaic acid and its comparison with topical clindamycin in the treatment of acne.
Methods
This randomized clinical trial study was performed on 100 patients with mild acne. The patients were divided in to two groups. One group was treated with azelaic acid 20% cream and the other one was treated with Dalacin 1% gel twice daily for 4 weeks.
Results
Both drugs Produced significant reduction in inflammatory Lesions (for azelaic acid p=0/000 and for clindamycin p=0/000) and noninflammatory lesions (for azelaic acid P=0/001 for clindamycin p=0/033). Comparing the mean of decrease in inflammatory and noninflammatory lesions, there was not a significant difference between two groups (of Papule and Pustule P=0/864 of comedons P=0/239). So the efficacy of these two drugs was same. In comparing the sideffects, erythem was more common in azelaic acid users significantly (p=0/031) and skin dryness was more Common in clindamycin users significantly (p=0/000).
Conclusion
Azelaic acid 20% cream as effective as clindamycin gel 1% in the treatment of mild acne.
Language:
Persian
Published:
Journal of Ardabil University of Medical Sciences, Volume:7 Issue: 24, 2007
Page:
137
magiran.com/p513586  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!